US-owned Egyptian vaccine maker to double down in Egypt
US-owned Egyptian vaccine maker could invest almost EGP 2 bn in new plants: Cairo-based vaccine manufacturer MEVAC plans to invest EGP 1.8 bn over three years to establish three new plants in Egypt for manufacturing veterinary and human vaccines, CEO Magdy El Sayed told GAFI chief Mohamed Abdel Wahab in a meeting this week, according to a cabinet statement.
MEVAC is majority-owned by US ingredients manufacturer Kemin, which acquired an undisclosed stake in the firm in March. The company has held a share of MEVAC since 2010 but recently upped its stake to increase its presence in the global vaccine market and became a shareholder in its sister firm UVAC.
Other future plans:The company also plans to build a 100-feddan farm for the production of eggs, which are used in manufacturing vaccines, El Sayed added, without specifying a timeline or an investment value.
About MEVAC: The company, founded in 2007, owns over 22 plants worldwide and exports its products to 15 countries worldwide.